Legal, Health and Regulatory Notice

Purchasing products through this platform is enabled exclusively for persons aged eighteen (18) or over with legal capacity to contract.

By continuing with the purchase, the Buyer expressly declares:

• that they are eighteen (18) years of age or older;
• that they have legal capacity to enter into the transaction;
• that the information provided during the purchase process is true, complete and up to date; and
• that they make the purchase in their own name or have sufficient authority to act on behalf of a third party where legally appropriate.

Persons under eighteen (18) are not authorized to make purchases through the platform. The Company may implement reasonable identity and age verification mechanisms, and may refrain from processing or completing a transaction when there are inconsistencies, false information or objective reasons to believe that this requirement is not met.

Before making payment, the Buyer declares having had access to the product page, description, presentation, contents, characteristics, warnings, restrictions and other relevant information available about the selected product.

The Buyer undertakes to read that information before purchasing or using the product and to observe the instructions, warnings, restrictions, storage conditions and other indications that legally apply.

This duty of information responds in particular to articles 23 and 24 of Law 1480 of 2011, which require clear, truthful, sufficient, timely, verifiable, understandable, precise and suitable information, and provide for information on instructions for use and storage.

The products offered are sold exclusively under the category and intended purpose «Research Use Only (RUO)», for research, analysis and/or laboratory purposes. The Company does not offer, promote or sell them under the name or status of medicines, medicinal products or products intended for the diagnosis, treatment, prevention, mitigation or cure of diseases, nor for consumption, application or administration in human beings.

Consequently, their purchase must not be interpreted as an offer or recommendation for medical use or for treatment. The Buyer must respect the RUO intended purpose, the technical specifications, and the storage, handling and labeling conditions and other restrictions applicable to the product.

The foregoing is without prejudice to the powers of INVIMA and other health authorities to determine the legal and health classification of a product based on its composition, objective characteristics, presentation, purpose and other relevant elements under applicable Colombian law. If the competent authority determines that a product is subject to a special health regime or requires prior registration, permit or authorization, its sale will be subject to compliance with the legally required conditions.

The information available on this website, product pages, educational content, publications, audiovisual material, electronic communications or scientific references has the scope expressly indicated in each case.

Except where legally appropriate and provided within a legally authorized professional relationship, that information does not constitute a diagnosis, medical consultation, prescription, medical formula, individualized treatment or personalized recommendation for treatment.

The Buyer must not use general information available on the platform as a substitute for an assessment by a health professional when one is necessary.

Reference to research, articles, scientific literature, preclinical or clinical studies, mechanisms of action or academic publications does not, by itself, mean that the specific product sold is authorized in Colombia to produce the effects studied or for the diagnosis, prevention or treatment of diseases.

When the product is a medicine, article 79 of Decree 677 of 1995 requires its scientific, promotional or advertising information to conform to the conditions of its health registration. Accordingly, the available scientific information must not be interpreted as extending the indications authorized by the health authority.

When a product is legitimately intended exclusively for scientific research, analysis or laboratory use and is not authorized for administration to human beings, the Buyer must strictly respect that intended purpose.

In such cases, the product must not be ingested, applied or administered to human beings by any route.

With respect to such products, the Company does not authorize or provide instructions on:

• amounts or frequencies of administration to people;
• treatment cycles or regimens;
• reconstitution intended for administration to people;
• application to the body by any route;
• treatment of diseases; or
• any other procedure intended to facilitate its administration to people.

The Company may refrain from completing or shipping a transaction when, before dispatch, it has objective elements that reasonably indicate that a product intended exclusively for research is meant to be used for a purpose incompatible with its classification or legal restrictions.

The Buyer undertakes not to deliberately use the product in a manner contrary to:

• its lawful purpose;
• the instructions and warnings provided;
• the applicable health restrictions;
• the storage conditions;
• the specific information on its labeling; or
• alerts or safety measures communicated later.

The Buyer acknowledges that the information, specifications, conditions of use, restrictions and warnings provided for the product form an integral part of the conditions under which it is offered and acquired.

Consequently, any use, handling or purpose that departs from those conditions, from the specifications reported or from the declared purpose of the product will be understood as an autonomous act of the Buyer or of the third party who performs it, outside the Company's sphere of control, authorization and responsibility.

When damage, harm or an adverse consequence results directly and causally from such an act, its consequences will be attributable to whoever carried out, arranged, authorized or facilitated the conduct that gave rise to the event. This will apply in accordance with the grounds for exemption provided in articles 16 and 22 of Law 1480 of 2011, particularly where there is improper use of the product, failure to follow the instructions provided, the act of a third party or, as the case may be, the exclusive fault of the injured party, and provided that its causal bearing on the outcome is proven.

The Buyer must refrain from using a product when:

• its packaging is open, tampered with or materially damaged;
• there are signs of tampering;
• its expiry date has passed, where applicable;
• it has not been stored under the required conditions;
• an applicable health alert or recall instruction exists; or
• there are objective reasons to doubt its identity or integrity.

The Buyer must not remove, replace or alter labels, batch numbers, expiry dates, warnings or identification and traceability elements of the product.

If INVIMA or another competent authority issues a health alert, recall order, suspension, prohibition, health safety measure or decision affecting a product, the Company may immediately take the actions needed to comply.

The Buyer undertakes to follow the safety instructions communicated and, where applicable, to immediately stop using the product and follow the return or recall procedure communicated by the Company.

If the Buyer identifies an adverse reaction, defect, alteration, apparent contamination, inconsistency, deterioration or any circumstance that could reasonably compromise the quality or safety of the product, they must stop using it where appropriate and report it to the Company through the institutional WhatsApp channel published on the contact page.

The report should state, where possible, the order code, the reference, the batch number and a description of what was observed.

The Company recognizes as official information only that published or provided through its authorized channels.

User comments, reviews, external publications, forums, social media, third-party content or statements made by persons not authorized to represent the Company do not constitute its instructions, recommendations or statements.

This clarification is relevant to digital advertising, since all information or commercial communication related to the product must correspond strictly to its nature, characteristics, declared purpose and conditions of sale, without attributing to it medicinal properties, or indications for use in humans, that do not belong to it.

The Buyer acknowledges that the instructions, restrictions and warnings in this document and in the specific product page are intended to promote informed purchase and use and to prevent misuse.

The Company will not be liable for damages, losses or consequences arising from acts, decisions, uses, handling or conduct attributable exclusively to the Buyer or to third parties, when these fall outside the Company's sphere of action and control and are the determining cause of the damage, in accordance with the grounds for exemption recognized by applicable Colombian law.

The determination of liability, causation, fault, defect, breach or concurrent causes must be made according to the particular circumstances and the applicable rules. The provisions of this document will be interpreted in accordance with applicable Colombian law and will have the maximum legally permitted scope.

No provision shall be understood as a waiver of non-waivable rights or as a modification of those liabilities that, by mandatory legal provision, do not admit exclusion or limitation.

The foregoing does not affect the application of the legal grounds for exemption, exclusion of liability, breaking of the causal link, exclusive act of the injured party or of third parties, improper use or failure to follow the instructions and warnings provided, where legally applicable.

In accordance with articles 42 and 43 of Law 1480 of 2011, these provisions must be interpreted preserving the mandatory rights of the consumer, without prejudice to the defenses, exceptions and grounds for exemption that Colombian law recognizes in favor of the Company.

Personal data provided during the purchase will be processed in accordance with the Company's Personal Data Processing Policy.

Health data is sensitive data under article 5 of Law 1581 of 2012 and its processing is subject to the special regime of article 6. When an authorization is necessary, the Company must state the purposes and obtain it on the corresponding terms.

Acceptance of this Notice does not by itself constitute a blanket authorization to process medical information or sensitive data.

This document is accepted electronically.

Articles 5 and 6 of Law 527 of 1999 recognize the legal effects of data messages and allow the written-form requirement to be met when the electronic information is accessible for later consultation. Its article 12 allows electronic retention under conditions of accessibility, integrity and preservation of information on origin, destination, date and time.

To evidence the information provided and the Buyer's expression of consent, the Company retains, in accordance with applicable law:

• identification of the transaction and the order code;
• date and time;
• product and reference code (SKU) of each line;
• the version of this Notice;
• the specific warnings shown on screen;
• the cryptographic digest (SHA-256) of the exact text presented;
• the IP address and user agent from which it was accepted; and
• other legitimately necessary technical evidence.

This Notice and the purchase transaction are governed by the laws of the Republic of Colombia.

Particularly relevant, depending on the nature and actual classification of the product, are: articles 19 and 79 of Decree 677 of 1995 on health registration and on information and advertising of medicines; articles 23, 24, 29, 30, 42, 43, 49 and 50 of Law 1480 of 2011, as amended, on information, advertising, contractual protection and electronic commerce; articles 5, 6 and 12 of Law 527 of 1999 on electronic contracting and evidence; and articles 5, 6 and 12 of Law 1581 of 2012 where sensitive or health-related data is processed.

Where applicable by the product's classification, Resolution 1896 of 2023 on information, advertising, promotion and sale of medicines and phytotherapeutic products will also be observed.

In case of conflict between this document and a mandatory rule, the applicable legal or regulatory provision will prevail.

Before enabling order confirmation, the platform requires:

• A mandatory checkbox in which the Buyer declares having read and understood this Legal, Health and Regulatory Notice and the specific warnings for the selected product, and that the purpose of the purchase is technical, research, institutional or laboratory. Without checking it, the confirmation button remains disabled.
• The declaration of legal age, shown visibly immediately before the confirmation button: by confirming the order, the Buyer declares that they are over eighteen (18) years of age, have legal capacity to contract and that the information provided is true.

Acceptance does not imply a waiver of the non-waivable rights recognized by Colombian law.

The Company sells technical material. It does not promote, recommend, suggest or induce any use of the material, and does not attribute to it any purpose, property, benefit or result of any kind.

In particular, and with respect to any catalog reference, the Company does not state or suggest:

• what it is for, what it can be used for or for what purpose it should be acquired;
• indications, or medicinal, preventive, curative, palliative, aesthetic, nutritional, or physical or cognitive performance properties;
• posology, administration amounts, cycles, protocols, schedules or combinations;
• routes or techniques of administration, reconstitution or preparation;
• equivalence, similarity or substitutability with respect to medicines or other products authorized by any health authority.

The information published about each reference is exclusively identifying in nature and describes the material itself: name, composition, presentation, quantity, declared purity and associated analytical documentation. Describing what a substance is does not amount to indicating what to use it for, and none of those descriptions should be interpreted as a recommendation, prescription, technical advice or invitation to use.

No communication issued by the Company or by those acting on its behalf, through any channel, including instant messaging, email, social media, catalogs and quotations, constitutes a recommendation for use or an indication of purpose. Any statement to the contrary is unauthorized and does not bind the Company.

The decision to acquire a given reference, and the purpose, destination and use given to it, belong exclusively to the Buyer, who makes them under their own judgment, autonomy and responsibility. By accepting this Notice, the Buyer declares that they have not received from the Company any guidance, suggestion or indication about the use of the material, and that their purchase decision is not based on any representation of that kind.

Statements made by third parties about the material, including users, content authors, forums, scientific or popular publications and unrelated advertisers, are not attributable to the Company and do not engage its liability, in accordance with article 11 of this Notice.

The Buyer will hold harmless the Company, its partners, directors, employees and contractors from any claim, lawsuit, investigation, complaint, sanction, fine, loss, cost or expense, including reasonable attorney's fees, arising from:

• the use of the material in humans or animals, or its administration, reconstitution, fractionation or preparation for that purpose;
• the resale, assignment, distribution, donation or delivery of the material to third parties, whether for profit or not;
• the inaccuracy or falsity of the Buyer's declarations when accepting this Notice, including the one on the purpose of the purchase;
• breach of the storage, handling, traceability or final disposal conditions set out in article 8; or
• the publication or dissemination by the Buyer of statements attributing to the material medicinal, preventive, curative, aesthetic or performance properties.

This obligation survives the end of the business relationship.

This clause will not apply to the extent that the claim arises from willful misconduct or gross negligence of the Company, and does not affect the non-waivable rights that Colombian law grants to consumers. In accordance with articles 42 and 43 of Law 1480 of 2011, any provision of this article that restricts a mandatory consumer right shall be deemed not written to that extent.

When the transaction is concluded through non-traditional or distance methods, a Buyer who is a consumer may exercise the right of withdrawal within five (5) business days following delivery of the goods, in accordance with article 47 of Law 1480 of 2011, except in the cases excluded by that same rule.

Once withdrawal has been exercised and the product returned in the legal conditions, the Company will refund the money paid within a maximum of fifteen (15) calendar days, in accordance with the amendment introduced by Law 2439 of 2024.

The Buyer may request a payment reversal in the events and under the procedure provided in article 51 of Law 1480 of 2011 and in articles 2.2.2.51.1 to 2.2.2.51.14 of Decree 1074 of 2015.

Disputes arising from this Notice will be submitted to the ordinary Colombian courts.

When the Buyer is a consumer, the foregoing is without prejudice to their right to go to the Superintendence of Industry and Commerce in exercise of the jurisdictional powers granted by article 58 of Law 1480 of 2011, and without prejudice to the rules of territorial jurisdiction established in their favor.